Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409965 · ClinicalTrials.gov registry record · NA
Lutronic Infini and LaseMD Systems in Combination Treatment
A NA study, sponsored by CynosureLutronic.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03409965 is a NA study that has completed, run by CynosureLutronic. The registered enrollment target is 21 participants.
The verdict
NCT03409965, a NA study, has completed, sponsored by CynosureLutronic.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This is a prospective, multi-site, non-randomized study evaluating the safety and effectiveness of the Infini and LaseMD Systems for combination treatment in wrinkles, texture, and pigmentation of the face and/or neck.
Interventions
- DEVICE Lutronic Infini System
- DEVICE Lutronic LaseMD System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-12-08 |
| Est. Completion | 2018-08-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03409965
The ClinicalTrials.gov registry entry for NCT03409965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CynosureLutronic, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lutronic Infini System is the first listed.
NCT03409965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03409965 about?
NCT03409965 is a clinical study titled "Lutronic Infini and LaseMD Systems in Combination Treatment". This is a prospective, multi-site, non-randomized study evaluating the safety and effectiveness of the Infini and LaseMD Systems for combination treatment in wrinkles, texture, and pigmentation of the face and/or neck.
What is the current status of trial NCT03409965?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-12-08. Estimated completion is 2018-08-21.
What interventions are being tested in trial NCT03409965?
The interventions under investigation include: Lutronic Infini System (DEVICE), Lutronic LaseMD System (DEVICE).
Who is sponsoring clinical trial NCT03409965?
This trial is sponsored by CynosureLutronic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.